← Leaderboards
John G Bruno
Operational Technologies Corporation
$1,346,550
Attributed
$1,346,550
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $534.5K · FY2012–16$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,346,550 · 4
By mechanism
R44$999,469 · 1
R43$347,081 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusFoundationsBaseCostDiagnosisFamilyAptamerArthritisCapsaicinCoronary Heart DiseaseAgonistAcute Inflammatory PainAmericanEvolutionAdverse EffectsAbsence Of Pain SensationAnalgesicsAfferent NeuronsAnimalsAffinity3-DimensionalChronic PainAntibodiesGated Ion Channel
Grant awards (5)
Development of Anti-OLAM Aptamers as Novel Analgesics (Phase 2)$464,965
R44 · FY2016 · GM · contact PI
Development of Anti-OLAM Aptamers as Novel Analgesics (Phase 2)$534,504
R44 · FY2015 · GM · contact PI
Development of Anti-OLAM Aptamers as Novel Analgesics$147,234
R43 · FY2012 · GM · contact PI
Nuclease-Resistant Aptamers for Anthrax Opsonization$99,934
R43 · FY2004 · AI
Nuclease-Resistant Aptamers to Botox and Anthrax Toxins$99,913
R43 · FY2004 · AI